NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Tuesday 29 January 2013

Manufacturing starts at Lonza Houston

Lonza has completed the validation of its new viral-induced cell processing GMP suites in Houston, TX, and has also completed the tech transfer process for a new virally-transfected T-cell product. Lonza said these new cell processing suites will allow it to develop virally-modified autologous cellular immunotherapies.
Lonza

No comments: